Status:
UNKNOWN
Vitamin D Effect on Subarachnoid Hemorrhage
Lead Sponsor:
University Clinic Frankfurt
Collaborating Sponsors:
Institut für Kardiovaskuläre Physiologie, Vascular Research Center
Conditions:
Vitamin D Deficiency
Eligibility:
All Genders
18+ years
Brief Summary
Vitamin D has been promoted to vascular regeneration in non-cerebral arteries because of its anti-inflammatory properties. Cerebral vasospasm (CVS) as the most feared complication after subarachnoid h...
Detailed Description
Subarachnoid hemorrhage (SAH) as a worldwide significant cause for morbidity and mortality, especially affecting young population, accounts for 4%-10% of all strokes. About 25% of SAH patients die and...
Eligibility Criteria
Inclusion
- Admitted patients suffering from SAH over 18 years of age with consent form.
Exclusion
- Admitted patients suffering from SAH younger than 18 years of age.
- SAH patients without consent form.
Key Trial Info
Start Date :
February 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03482843
Start Date
February 1 2017
End Date
December 31 2019
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Goethe University Hospital
Frankfurt am Main, Germany